BORIS BLECHACZ to Kaplan-Meier Estimate
This is a "connection" page, showing publications BORIS BLECHACZ has written about Kaplan-Meier Estimate.
Connection Strength
0.013
-
Genomic and genetic characterization of cholangiocarcinoma identifies therapeutic targets for tyrosine kinase inhibitors. Gastroenterology. 2012 Apr; 142(4):1021-1031.e15.
Score: 0.013